Prevention of Cervical Cancer in Central and Eastern Europe and Central Asia: A Challenge for the Future

Vaccine

Volumn 31, Issue S7, 2013, Pages

  Kesic, Vesna ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ASIA; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; EASTERN EUROPE; EDITORIAL; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SEXUAL BEHAVIOR; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VACCINATION; WART VIRUS;

ADOLESCENT; ASIA, CENTRAL; CHILD; EARLY DETECTION OF CANCER; EUROPE, EASTERN; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84890175005     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.11.105     Document Type: Editorial

References (24)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available at: http://globocan.iarc.fr. (last accessed March 2013).
2. Arbyn M., Antoine J., Magi M., Smailyte G., Stengrevics A., Suteu O., et al. Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania. Int J Cancer 2011, 128:1899-1907.
3. Bray F., Lortet-Tieulent J., Znaor A., Brotons M., Poljak M., Arbyn M. Patterns and Trends in Human Papillomavirus-Related Diseases in Central and Eastern Europe and Central Asia. Vaccine 2013, 31S:H32-H45.
4. Bruni L., Diaz M., Castellsagué X., Ferrer E., Bosch X.F., de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010, 202(12):1789-1799.
5. Crochard A., Luyts D., di Nicola S., Gonçalves M.A. Self-reported sexual debut and behavior in young adults aged 18-24 years in seven European countries: implications for HPV vaccination programs. Gynecol Oncol 2009, 115(3 Suppl):S7-S14.
6. Rogovskaya S.I., Mikheyeva I.V., Shipulina O.U., Minkina G.N., Podzolkova N.M., Radzinsky V.E. Prevalence of human papillomavirus infection in Russia. Epidemiology Vaccinoprophilaxis 2012, 62:25-33.
7. World Health Organization. Report on the global tobacco Epidemic, 2008. The MPOWER package. Available at: (last accessed March 2013). http://www.who.int/tobacco/mpower/mpower_report_full_2008.pdf.
8. UNAIDS Global Report. Facts sheet Eastern Europe and Central Asia. Available at: (last accessed March 2013). http://www.unaids.org/documents/20101123_FS_eeca_em_en.pdf.
9. Denny L., Boa R., Williamson A-L., Allan B., Hardie D., Stan R., et al. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet Gynecol 2008, 111:1380-1387.
10. Denny L.A., Franceschi S., de Sanjosé S., Heard I., Moscicki A.B., Palefsky J. Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine 2012, 30(Suppl 5):F168-F174.
11. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. European guidelines for quality assurance in cervical cancer screening (2nd ed.). Brussels, Luxembourg: European Community, Office for Official Publications of the European Communities;2008.
12. Nicula F., Anttila A., Neamtiu L., Žakelj M.P., Tachezy R., Chil A., et al. Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union. Eur J Cancer 2009, 45:2679-2684.
13. Poljak M., Seme K., Maver P.J., Kocjan B.J., Cuschieri K.S., Rogovskaya S.I., et al. Human Papillomavirus Prevalence and Type-Distribution. Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Central and Eastern Europe. Vaccine 2013, 31S:H59-H70.
14. Rogovskaya S.I., Shabalova I.P., Mikheeva I.V., Minkina G.N., Podzolkova N.M., Shipulina O.Y., et al. Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in the Russian Federation, the Western Countries of the former Soviet Union, Caucasus region and Central Asia. Vaccine 2013, 31S:H46-H58.
15. Lynge E., Rebolj M. Primary HPV screening for cervical cancer prevention: results from European trials. Nat Rev Clin Oncol 2009, 6:699-706.
16. International Agency for Research on Cancer. Cervix cancer screening. IARC handbooks of cancer prevention, vol. 10. Lyon: IARC Press; 2005. p. 1-302.
17. Spence A.R., Goggin P., Franco E.L. Process of care failures in invasive cervical cancers: A systematic review and meta-analysis. Prev Med 2007, 45:93-106.
18. Arbyn M., Ronco G., Meijer C.J., Naucler P. Trials comparing cytology with human papillomavirus screening. Lancet Oncol 2009, 10:935-936.
19. Rijkaart DC, Berkhof J, van Kemenade FJ, Coupe VM, Rozendaal L, Heideman DA, et al. HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications. Br J Cancer 2012;106(5):975-81.
20. Kitchener H.C., Almonte M., Thomson C., Wheeler P., Sargent A., Stoykova B., et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 2009, 10:672-682.
21. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010 Mar;11(3):249-57.
22. Dillner J., Rebolj M., Birembaut P., Petry K.U., Szarewski A., Munk C., et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 2008, 377:a1754.
23. de Kok I.M., van Rosmalen J., Dillner J., Arbyn M., Sasieni P., Iftner T., et al. Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model. BMJ. 2012, 344:e670.
24. Poljak M., Rogovskaya S.I., Kesic V., Bray F., Berkhof J., Seme K., et al. Recommendations for Cervical Cancer Prevention in Central and Eastern Europe and Central Asia. Vaccine 2013, 31S:H80-H82.